Everolimus Vipharm

Everolimus Vipharm is an oral medication used for various therapeutic purposes. This pharmaceutical is manufactured by Vipharm S.A. and is designed for oral use.

Everolimus is primarily used to support immune system suppression and to aid in the prevention of organ rejection following transplants. It is also utilized in the management of certain types of cancer, particularly those affecting the kidneys and breasts. Everolimus works by targeting specific proteins in the body to slow down the growth of cancer cells and to modulate the immune response.

Common effects of Everolimus may include fatigue, mouth sores, and an increased risk of infections. Some individuals might experience swelling, nausea, or changes in appetite. It is important to monitor for any unusual symptoms and consult a healthcare provider if significant side effects occur.

Everolimus should be handled with care, especially by individuals with a history of liver or kidney problems. It is crucial to follow the prescribed dosage and administration guidelines to minimize potential risks. Regular medical check-ups are recommended to monitor the body's response to the medication.

Everolimus may interact with certain medications, including those that affect liver enzymes, such as CYP3A4 inhibitors and inducers. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be moderated while using Everolimus.